Skip to content

Clinical trials

Phase 2 Eczema trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Eczema Phase: Phase 2 Country / region: Canada Clear all

44 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20133
20141
20152
20172
20186
20195
20201
20213
20225
20234
20243
20256
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Terminated8
Recruiting5
Active, not recruiting2
Unknown status2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer6
Asana BioSciences3
Novartis Pharmaceuticals3
ASLAN Pharmaceuticals2
Apollo Therapeutics Ltd2
Evelo Biosciences, Inc.2
GlaxoSmithKline2
Incyte Corporation2
Inmagene LLC2
Regeneron Pharmaceuticals2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Eczema44
Dermatitis, Atopic41
Dermatitis12
Skin Diseases11
Immune System Diseases5
Pruritus4
Genetic Diseases, Inborn1
Hypersensitivity1
Hypersensitivity, Immediate1
Inflammation1

Trials

Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.